Showing results (61-70 of 96) with videos related to

Sort By:
Pageof 10
European Journal of Heart Failure|July 5, 2020
Association between glycated haemoglobin levels and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the TECOS randomized clinical trialFinlay A McAlister, Yinggan Zheng, Cynthia M Westerhout, et al.
Diabetes Research and Clinical Practice|February 29, 2020
Proceedings of the Guideline Workshop 2019 - Strategies for the optimization of guideline processes in diabetes, cardiovascular diseases and kidney diseasesNikolaus Marx, Lars Rydén, Frank Brosius, et al.
Diabetes Technology & Therapeutics|September 9, 2020
Proceedings of the Guideline Workshop 2019: Strategies for the Optimization of Guideline Processes in Diabetes, Cardiovascular Diseases, and Kidney DiseasesNikolaus Marx, Lars Rydén, Frank Brosius, et al.
Diabetes Care|January 7, 2017
Assessing the Safety of Sitagliptin in Older Participants in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)M Angelyn Bethel, Samuel S Engel, Jennifer B Green, et al.
Diabetes Care|January 10, 2018
Increased Risk of Severe Hypoglycemic Events Before and After Cardiovascular Outcomes in TECOS Suggests an At-Risk Type 2 Diabetes Frail Patient PhenotypeEberhard Standl, Susanna R Stevens, Paul W Armstrong, et al.
Stroke|August 1, 2013
Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trialDavid Preiss, Thomas D Giles, Laine E Thomas, et al.
Hypertension (Dallas, Tex. : 1979)|August 30, 2017
Hypertension Control in Adults With Diabetes Mellitus and Recurrent Cardiovascular Events: Global Results From the Trial Evaluating Cardiovascular Outcomes With SitagliptinAnn Marie Navar, Dianne S Gallup, Yuliya Lokhnygina, et al.
BMJ Open|December 4, 2012
Predictors of cardiovascular events in a contemporary population with impaired glucose tolerance: an observational analysis of the Nateglinide and Valsartan in impaired glucose tolerance outcomes research (NAVIGATOR) trialDavid Preiss, Laine E Thomas, Jie-Lena Sun, et al.
Diabetes Research and Clinical Practice|May 27, 2021
Towards living guidelines on cardiorenal outcomes in diabetes: A pilot project of the Taskforce of the Guideline Workshop 2020Nikolaus Marx, Lars Ryden, Frank Brosius, et al.
American Heart Journal|November 11, 2019
International variation in characteristics and clinical outcomes of patients with type 2 diabetes and heart failure: Insights from TECOSAnkeet S Bhatt, Nancy Luo, Nicole Solomon, et al.
Pageof 10